Search

everythinglearnresearchcommunity

for

Search:↓

Combining stem cells with ATP significantly boosts hair regrowth in mice with hair loss.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Finasteride, a medication, is being re-evaluated for its effects and uses.

DA-9401 helps protect rat testis from finasteride damage.

Caucasian men have more chest hair and higher levels of certain androgen products than Chinese men.

Simple methods using DHT levels effectively assess compliance.

Finasteride may help reduce male hair loss and excessive hair growth by lowering DHT levels.

Finasteride reduces hair loss by blocking testosterone's effects on scalp cells.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Type 2 5α-reductase plays a key role in hair loss.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Finasteride lowers cortisol and raises testosterone levels in rats.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Anabolic steroids and inflammation can disrupt androgen metabolism, potentially causing health issues.

Long-term use of a drug for hair loss and prostate issues can cause metabolic problems and depression-like behavior in young male rats.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.